External composition, and preparation and application thereof

A composition for external use and the technology of the composition, applied in the field of medicine, can solve the problems of destroying the balance of vaginal microenvironment, poor treatment effect and high recurrence rate, and achieve the effects of improving vaginal microenvironment, strong antibacterial property and repairing vaginal inflammation

Active Publication Date: 2013-07-03
JIANGSU DIWO BIOLOGICAL PROD
View PDF7 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] In order to overcome the defects of destroying the balance of vaginal microenvironment, poor treatment effect and high recurrence rate in the existing treatment process of vaginal inflammation, and drug toxicity in the process of skin wound repair Effect disadvantages, the present invention provides a new pharmaceutical composition for vaginal inflammation and skin wound repair,

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • External composition, and preparation and application thereof
  • External composition, and preparation and application thereof
  • External composition, and preparation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Embodiment 1: gel of the present invention

[0044] A gel used for repairing vaginal mucosa, cervical mucosa or skin wounds. The ingredients include chitosan, sodium hyaluronate, chlorhexidine and recombinant human epidermal growth factor. The mass percentage includes: 30000 parts of chitosan, 3000 parts of sodium hyaluronate, 3000 parts of chlorhexidine and 0.1 part of recombinant human epidermal growth factor.

[0045] Take the preparation of one kilogram of gel as an example,

[0046] 30g chitosan

[0047] 3g sodium hyaluronate

[0048] 3g chlorhexidine

[0049] 0.1mg recombinant human epidermal growth factor

[0050] Preparation:

[0051] (1) Add chitosan and sodium hyaluronate to 960 ml of purified water, and dissolve them with a disperser;

[0052] (2) Disperse chlorhexidine in 5 ml of propylene glycol;

[0053] (3) Add the chlorhexidine propylene glycol suspension into the above solution of chitosan and sodium hyaluronate, stir to mix the components ev...

Embodiment 2

[0057] Embodiment 2: gel agent of the present invention

[0058] A gel for repairing vaginal mucosa, cervical mucosa or skin wounds, comprising: 50,000 parts of chitosan, 1,000 parts of sodium hyaluronate, 1,000 parts of chlorhexidine acetate, 5 parts of recombinant human epidermal growth factor.

[0059] Take the preparation of one kilogram of gel as an example,

[0060] 50g chitosan

[0061] 1g sodium hyaluronate

[0062] 1g chlorhexidine acetate

[0063] 5mg recombinant human epidermal growth factor

[0064] Preparation:

[0065] (1) Add chitosan and sodium hyaluronate to 960 ml of purified water, and dissolve them with a disperser;

[0066] (2) Disperse chlorhexidine acetate in 5 ml of propylene glycol;

[0067] (3) Add the chlorhexidine acetate propylene glycol suspension into the above-mentioned solution of chitosan and sodium hyaluronate, and stir to mix the components evenly;

[0068] (4) Adjust the pH value of the solution between 5.0 and 6.0, and continue t...

Embodiment 3

[0071] Embodiment 3: gel agent of the present invention

[0072] A gel for repairing vaginal mucosa, cervical mucosa or skin wounds, comprising: 40,000 parts of chitosan, 1,000 parts of sodium hyaluronate, 2,000 parts of chlorhexidine gluconate, 0.4 parts of recombinant human epidermal growth factor.

[0073] Take the preparation of one kilogram of gel as an example,

[0074] 40g chitosan

[0075] 1g sodium hyaluronate

[0076] 2g Chlorhexidine Gluconate

[0077] 0.4mg recombinant human epidermal growth factor

[0078] Preparation:

[0079] (1) Add chitosan and sodium hyaluronate to 960 ml of purified water, and dissolve them with a disperser;

[0080] (2) Disperse chlorhexidine gluconate in 5 ml of propylene glycol;

[0081] (3) Add the chlorhexidine gluconate propylene glycol suspension into the above solution of chitosan and sodium hyaluronate, stir to mix the components evenly,

[0082] (4) Adjust the pH value of the solution between 5.0 and 6.0, and continue to ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an external composition, and a preparation and an application thereof and belongs to the field of medicines. The external composition provided by the invention is a medicine composition which contains chlorhexidine or officinal salt thereof, or benzalkonium bromide or officinal salt thereof and a recombinant human epidermal growth factor or a recombinant cattle alkali fibroblast growth factor. According to the invention, the medicine composition is also further prepared into gel, liniment, ointment or paste, and the gel further comprises chitosan or officinal salt thereof and hyaluronic acid or officinal salt thereof. When being used for treating vagina inflammation, the external composition disclosed by the invention can improve a vagina microenvironment, promote growth of granulation tissue and repair vagina micro damage; and when being used for skin wound atraumatic restorative treatment, the external composition also can speed up restoration and regeneration of a wound tissue, promote healing and reduce scar formation, so that the external composition has a wide medical application prospect.

Description

technical field [0001] The invention relates to an external composition, preparation and application thereof, in particular to a pharmaceutical composition containing recombinant human epidermal growth factor and its medical application for preparing and treating vaginal inflammation or skin wound repair, belonging to the field of medicine. Background technique [0002] Vaginitis is a general term for a variety of vaginal mucosal inflammatory diseases caused by different etiologies. It is a common and frequently-occurring disease in gynecological outpatient clinics. Vaginal inflammation is mainly caused by bacteria, fungi, chlamydia, viruses, protozoa, etc. If the source of vaginal infection is not treated in time, it can go up to the uterine cavity, fallopian tubes, ovaries and pelvic cavity, resulting in acute and chronic endometritis, salpingitis, and ovarian inflammation Or pelvic inflammatory disease, in addition to inflammation symptoms, chronic infection may even caus...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/18A61K9/06A61P15/02A61P15/00A61P17/02A61K31/155A61K31/14
Inventor 贾峻峰
Owner JIANGSU DIWO BIOLOGICAL PROD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap